Ethylmalonate

Ethylmalonate

SCHEMBL8330729

CCC(C(=O)[O-])C(=O)[O-].CCC(C(=O)[O-])C(=O)[O-].[Mg+2].[Mg+2]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ATP4AATP4BGABBR1GABBR2HMGCR

The experimentally established mechanism targets of Ethylmalonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.43
TSHR P16473 2/20 0.43
NFKB1 P19838 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
CA2 P00918 2/20 0.41
CA1 P00915 3/20 0.37
FFAR3 O14843 2/20 0.36
HDAC3 O15379 2/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC2 Q92769 2/20 0.36
HDAC8 Q9BY41 2/20 0.36
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylmalonate SCHEMBL5236393 1.00 CYP3A4 (0.43) CYP3A4TSHRNFKB1NPSR1CA2
Ethylmalonate SCHEMBL30534801 0.94 CYP3A4 (0.43) CYP3A4TSHRNFKB1NPSR1CA2
Ethylmalonate SCHEMBL108809 0.94 CYP3A4 (0.43) CYP3A4TSHRNFKB1NPSR1CA2
Ethylmalonate SCHEMBL29035614 0.94 CYP3A4 (0.43) CYP3A4TSHRNFKB1NPSR1CA2
Ethylmalonate SCHEMBL108038 0.94 CYP3A4 (0.48) CYP3A4TSHRNFKB1NPSR1CA2
Ethylmalonate SCHEMBL9765249 0.94 CYP3A4 (0.43) CYP3A4TSHRNFKB1NPSR1CA2
Ethylmalonate SCHEMBL9118939 0.94 CYP3A4 (0.43) CYP3A4TSHRNFKB1NPSR1CA2
Ethylmalonate SCHEMBL21269702 0.94 CYP3A4 (0.43) CYP3A4TSHRNFKB1NPSR1CA2
Ethylmalonate SCHEMBL21269525 0.94 CYP3A4 (0.43) CYP3A4TSHRNFKB1NPSR1CA2
Ethylmalonate SCHEMBL29018393 0.94 CYP3A4 (0.43) CYP3A4TSHRNFKB1NPSR1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0559774-B1 INDIVIDUAL STEREOISOMERS OF 7- 3-(1-AMINOALKYL)-1-PYRROLIDINYL]-QUINOLONES AND NAPHTHYRIDONES AS ANTIBACTERIAL AGENTS WARNER LAMBERT CO (US) 1999-07-07 EP disclosed
EP-0909759-A2 Individual stereoisomers of 7-(3-aminoalkyl)-1-pyrrolidinyl)-quinolones as antibacterial agents WARNER-LAMBERT COMPANY (US) 1999-04-21 EP disclosed
EP-0810991-B1 1-ARYL-2-ACYLAMINO-ETHANE COMPOUNDS AND THEIR USE AS NEUROKININ ESPECIALLY NEUROKININ 1 ANTAGONISTS NOVARTIS AG (CH) 1999-04-14 EP disclosed
EP-0810991-A1 1-ARYL-2-ACYLAMINO-ETHANE COMPOUNDS AND THEIR USE AS NEUROKININ ESPECIALLY NEUROKININ 1 ANTAGONISTS Novartis AG (CH) 1997-12-10 EP disclosed
US-5633264-A Individual stereoisomers of 7-[3-(1-aminoalkyl)-1-pyrrolidinyl]-Quinolones and naphthyridones as antibacterial agents WARNER-LAMBERT COMPANY (US) 1997-05-27 US disclosed
EP-0464817-B1 2,4-Dihydroxyadipic acid derivative KANEGAFUCHI CHEMICAL IND (JP) 1996-10-09 EP disclosed
US-5563155-A QUINOLONE ANTIBIOTICS WITH INCREASED EFFICACY, REDUCED SIDE EFFECTS WARNER-LAMBERT COMPANY (US) 1996-10-08 US disclosed
WO-1996026183-A1 1-ARYL-2-ACYLAMINO-ETHANE COMPOUNDS AND THEIR USE AS NEUROKININ ESPECIALLY NEUROKININ 1 ANTAGONISTS NOVARTIS AG (CH) 1996-08-29 WO disclosed
US-5461165-A Individual stereoisomers of intermediates of 7-[3-(1-aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents WARNER-LAMBERT COMPANY (US) 1995-10-24 US disclosed
US-5344940-A Bactericides WARNER-LAMBERT COMPANY (US) 1994-09-06 US disclosed
EP-0559774-A1 INDIVIDUAL STEREOISOMERS OF 7- 3-(1-AMINOALKYL)-1-PYRROLIDINYL]-QUINOLONES AND NAPHTHYRIDONES AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1993-09-15 EP disclosed
US-5214197-A 2,4-DIHYDROXYADIPIC ACID DERIVATIVE KANEGAFUCHI CHEMICAL INDUSTRY CO., LTD. (JP) 1993-05-25 US disclosed
US-5175356-A Trifluorobenzoic acid intermediates WARNER-LAMBERT COMPANY (US) 1992-12-29 US disclosed
US-5116834-A Quinolinecarboxylic acid antibacterial agents WARNER-LAMBERT COMPANY (US) 1992-05-26 US disclosed
EP-0464817-A1 2,4-Dihydroxyadipic acid derivative Kanegafuchi Chemical Industry Co., Ltd. (JP) 1992-01-08 EP disclosed
WO-1991016312-A1 QUINOLINECARBOXYLIC ACID ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY (US) 1991-10-31 WO disclosed
US-5047538-A Quinolinecarboxylic acid antibacterial agents WARNER-LAMBERT COMPANY (US) 1991-09-10 US disclosed
US-4916229-A Pyridine carboxylic acid derivates WARNER-LAMBERT COMPANY (US) 1990-04-10 US disclosed
US-4870199-A FROM 3-HYDROXY-4-TRIPHENYLMETHOXYBUTANOIC ACID SANDOZ PHARM. CORP. (US) 1989-09-26 US disclosed
EP-0244364-A2 Preparation of olefinic compounds SANDOZ AG (CH) 1987-11-04 EP disclosed